| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Secure64 Software Corporation is one of the leading providers in Software and Internet. It is based in Greenwood Vlg, CO. To find more information about Secure64 Software Corporation, please visit www.secure64.com.
Your Data Creation Partner. Walr delivers digital data solutions, customised to drive your success. Learn more today.
Epik is an American domain registrar and web hosting company known for providing services to websites that host far-right, neo-Nazi, and other extremist content.
Cyberonix is a Oakland, CA-based company in the Software and Internet sector.